Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

Abstract

Betaine is a safe and well tolerated drug that leads to a significant biochemical and histological improvement in patients with NASH. This novel agent deserves further evaluation in a randomized, placebo-controlled trial.